Examples of using Diffuse cutaneous in English and their translations into Portuguese
{-}
-
Colloquial
-
Official
-
Medicine
-
Financial
-
Ecclesiastic
-
Ecclesiastic
-
Computer
-
Official/political
Patient P2, age 58, had the diffuse cutaneous form of SSc for 12 years
Interstitial disease is more often accompanied by the diffuse cutaneous form of PSS, whereas PH is more common in the limited cutaneous form,
there were 6 cases of anergic diffuse cutaneous leishmaniasis(adcldth-) and borderline disseminated cutaneous leishmaniasis(bdcldth-)
years mean± standard deviation: 42.8± 13.5 years, disease duration ranged from 0.3 to 30 years median, 4 years, and 63.8% of the patients presented diffuse cutaneous disease.
nevertheless in some cases may present a more severe form called diffuse cutaneous leishmaniasis.
Patient P1, age 31, presented the diffuse cutaneous form of SSc overlapping with systemic lupus erythematosus for 9 years,
disseminated cutaneous leishmaniasis(dl), diffuse cutaneous leishmaniasis(dcl), cutis recidivans leishmaniasis(crl) and mucosal form.
localizated cutaneous, diffuse cutaneous, disseminated cutaneous,
The patient developed diffuse cutaneous and conjunctive petechiaes,
in about 28-70% patients with the diffuse cutaneous SSc and in less than 10% of patients with limited scleroderma.
In this study, the anti-topo I autoantibody was mainly correlated with the diffuse cutaneous SSc, with greater disease severity
25 26.04% had the diffuse cutaneous form, and eight 8.33% were classified as"other forms" overlap of SSc and rheumatoid arthritis RA, systemic lupus erythematosus SLE,
disseminated cutaneous leishmaniasis and diffuse cutaneous leishmaniasis. The clinical manifestations of the disease are determined by the characteristics of the host,
31 with SSc including limited and diffuse cutaneous forms, MCTD and the patterns overlapping with SLE,
longitudinal melanonychia of 20 nails, diffuse cutaneous xerosis, ichthyosiform lesions on legs,
Of these 8 patients, 3 had diffused cutaneous dissemination, even at sites distant from the site of the primary tumor.
a selective agonist of the CB2 receptor for the treatment of diffuse cutaneous systemic sclerosis“scleroderma”.
Prognostic Marker Markers for diffuse cutaneous SSc are anti-fibrillarin(up to 64%), anti-RNA-Pol III(up to 85%),
a selective agonist of the CB2 receptor for the treatment of diffuse cutaneous systemic sclerosis"scleroderma.